Personal CFO Solutions’s Ascendis Pharma A/S ASND Stock Holding History

Personal CFO Solutions’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$384K	Sell	1,441 -78	-5%	-$18.2K	0.06%	327
2026 Q1	$347K	Buy	1,519 +64	+4%	+$14.3K	0.05%	334
2025 Q4	$310K	Buy	1,455 +108	+8%	+$22.3K	0.05%	354
2025 Q3	$268K	Buy	1,347 +7	+0.5%	+$1.31K	0.05%	382
2025 Q2	$231K	Buy	+1,340	New	+$218K	0.04%	420

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Personal CFO Solutions's ASND Position: Q2 2026 in Review

Personal CFO Solutions reduced its Ascendis Pharma A/S (ASND) stake by 5.1% in Q2 2026, selling an estimated $18.2K and leaving 1,441 shares worth $384K. The position accounts for 0.06% of the portfolio, ranked #327.

Personal CFO Solutions first reported a position in ASND in Q2 2025 and has held it in 5 quarters since. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Personal CFO Solutions held 1,441 shares of Ascendis Pharma A/S worth $384K as of Q2 2026.
Personal CFO Solutions sold 78 Ascendis Pharma A/S shares in Q2 2026, an estimated $18.2K.
Ascendis Pharma A/S made up 0.06% of Personal CFO Solutions's portfolio in Q2 2026, its #327 holding.
Personal CFO Solutions first reported a position in Ascendis Pharma A/S in Q2 2025 and has held it in 5 quarters since.
312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Personal CFO Solutions's 13F filing for Q2 2026, filed 7 Aug 2026.